Lineage-Specific Viral Hijacking of Non-canonical E3Ubiquitin Ligase Cofactors in the Evolution of Vif Anti-APOBEC3 Activity

Cell Reports

Volumn 11, Issue 8, 2015, Pages 1236-1250

  Kane, Joshua R ^a,b,e   Stanley, David J ^c   Hultquist, Judd F ^a,b,d,e   Johnson, Jeffrey R ^a,b,e   Mietrach, Nicole ^f   Binning, Jennifer M ^c   Jónsson, Stefán R ^f   Barelier, Sarah ^c   Newton, Billy W ^a,b,e   Johnson, Tasha L ^a,b,e   Franks Skiba, Kathleen E ^a,b   Li, Ming ^d   Brown, William L ^d   Gunnarsson, Hörour I ^f   Adalbjornsdóttir, Adalbjorg ^f   Fraser, James S ^b,c   Harris, Reuben S ^d   Andrésdóttir, Valgerour ^f   Gross, John D ^c   Krogan, Nevan J ^a,b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e GLADSTONE INSTITUTES   (United States)

^f UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN A; UBIQUITIN PROTEIN LIGASE E3; VIF PROTEIN; APOBEC3 PROTEIN, HUMAN; CYTOSINE DEAMINASE; PROTEIN BINDING; UBIQUITIN PROTEIN LIGASE;

ARTICLE; BINDING SITE; COMPARATIVE STUDY; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEOMICS; SIMIAN IMMUNODEFICIENCY VIRUS; STRUCTURE ANALYSIS; UBIQUITINATION; VIRUS CELL INTERACTION; ANIMAL; ANTAGONISTS AND INHIBITORS; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; SHEEP;

HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; CYTOSINE DEAMINASE; GENE PRODUCTS, VIF; HIV-1; HUMANS; PROTEIN BINDING; SHEEP; UBIQUITIN-PROTEIN LIGASES;

EID: 84929953567     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.04.038     Document Type: Article

References (71)

1. Ai Y., Zhu D., Wang C., Su C., Ma J., Ma J., Wang X. Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation. J.Virol. 2014, 88:12112-12122.
2. Beltrao P., Cagney G., Krogan N.J. Quantitative genetic interactions reveal biological modularity. Cell 2010, 141:739-745.
3. Binka M., Ooms M., Steward M., Simon V. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H. J.Virol. 2012, 86:49-59.
4. Bogerd H.P., Tallmadge R.L., Oaks J.L., Carpenter S., Cullen B.R. Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism. J.Virol. 2008, 82:11889-11901.
5. Bosco D.A., Eisenmesser E.Z., Clarkson M.W., Wolf-Watz M., Labeikovsky W., Millet O., Kern D. Dissecting the microscopic steps of the cyclophilin A enzymatic cycle on the biological HIV-1 capsid substrate by NMR. J.Mol. Biol. 2010, 403:723-738.
6. Braaten D., Luban J. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human Tcells. EMBO J. 2001, 20:1300-1309.
7. Choi H., Larsen B., Lin Z.-Y., Breitkreutz A., Mellacheruvu D., Fermin D., Qin Z.S., Tyers M., Gingras A.-C., Nesvizhskii A.I. SAINT: probabilistic scoring of affinity purification-mass spectrometry data. Nat. Methods 2011, 8:70-73.
8. Davis Z.H., Verschueren E., Jang G.M., Kleffman K., Johnson J.R., Park J., Von Dollen J., Maher M.C., Johnson T., Newton W., et al. Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes. Mol. Cell 2015, 57:349-360.
9. Derse D., Hill S.A., Princler G., Lloyd P., Heidecker G. Resistance of human Tcell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid. Proc. Natl. Acad. Sci. USA 2007, 104:2915-2920.
10. Etienne L., Hahn B.H., Sharp P.M., Matsen F.A., Emerman M. Gene loss and adaptation to hominids underlie the ancient origin of HIV-1. Cell Host Microbe 2013, 14:85-92.
11. Fischer G., Bang H., Mech C. [Determination of enzymatic catalysis for the cis-trans-isomerization of peptide binding in proline-containing peptides]. Biomed. Biochim. Acta 1984, 43:1101-1111.
12. Fischer G., Wittmann-Liebold B., Lang K., Kiefhaber T., Schmid F.X. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 1989, 337:476-478.
13. Fregoso O.I., Ahn J., Wang C., Mehrens J., Skowronski J., Emerman M. Evolutionary toggling of Vpx/Vpr specificity results in divergent recognition of the restriction factor SAMHD1. PLoS Pathog. 2013, 9:e1003496.
14. Gamble T.R., Vajdos F.F., Yoo S., Worthylake D.K., Houseweart M., Sundquist W.I., Hill C.P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 1996, 87:1285-1294.
15. Greninger A.L., Knudsen G.M., Betegon M., Burlingame A.L., Derisi J.L. The 3A protein from multiple picornaviruses utilizes the golgi adaptor protein ACBD3 to recruit PI4KIIIβ. J.Virol. 2012, 86:3605-3616.
16. Gudmundsson B., Jónsson S.R., Olafsson O., Agnarsdóttir G., Matthíasdóttir S., Georgsson G., Torsteinsdóttir S., Svansson V., Kristbjornsdóttir H.B., Franzdóttir S.R., et al. Simultaneous mutations in CA and Vif of Maedi-Visna virus cause attenuated replication in macrophages and reduced infectivity invivo. J.Virol. 2005, 79:15038-15042.
17. Guo Y., Dong L., Qiu X., Wang Y., Zhang B., Liu H., Yu Y., Zang Y., Yang M., Huang Z. Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif. Nature 2014, 505:229-233.
18. Han X., Liang W., Hua D., Zhou X., Du J., Evans S.L., Gao Q., Wang H., Viqueira R., Wei W., et al. Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase. J.Virol. 2014, 88:3320-3328.
19. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 2003, 113:803-809.
20. He N., Liu M., Hsu J., Xue Y., Chou S., Burlingame A., Krogan N.J., Alber T., Zhou Q. HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Mol. Cell 2010, 38:428-438.
21. Huang G., Shigesada K., Ito K., Wee H.J., Yokomizo T., Ito Y. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J. 2001, 20:723-733.
22. Hultquist J.F., Lengyel J.A., Refsland E.W., LaRue R.S., Lackey L., Brown W.L., Harris R.S. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J.Virol. 2011, 85:11220-11234.
23. Hultquist J.F., Binka M., LaRue R.S., Simon V., Harris R.S. Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors. J.Virol. 2012, 86:2874-2877.
24. Iwatani Y., Chan D.S.B., Wang F., Maynard K.S., Sugiura W., Gronenborn A.M., Rouzina I., Williams M.C., Musier-Forsyth K., Levin J.G. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res. 2007, 35:7096-7108.
25. Jäger S., Cimermancic P., Gulbahce N., Johnson J.R., McGovern K.E., Clarke S.C., Shales M., Mercenne G., Pache L., Li K., et al. Global landscape of HIV-human protein complexes. Nature 2012, 481:365-370.
26. Jäger S., Kim D.Y., Hultquist J.F., Shindo K., LaRue R.S., Kwon E., Li M., Anderson B.D., Yen L., Stanley D., et al. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection. Nature 2012, 481:371-375.
27. Jarmuz A., Chester A., Bayliss J., Gisbourne J., Dunham I., Scott J., Navaratnam N. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 2002, 79:285-296.
28. Jáuregui P., Crespo H., Glaria I., Luján L., Contreras A., Rosati S., de Andrés D., Amorena B., Towers G.J., Reina R. Ovine TRIM5α can restrict visna/maedi virus. J.Virol. 2012, 86:9504-9509.
29. Jaya N., Garcia V., Vierling E. Substrate binding site flexibility of the small heat shock protein molecular chaperones. Proc. Natl. Acad. Sci. USA 2009, 106:15604-15609.
30. Katzourakis A., Tristem M., Pybus O.G., Gifford R.J. Discovery and analysis of the first endogenous lentivirus. Proc. Natl. Acad. Sci. USA 2007, 104:6261-6265.
31. Kawakami T., Sherman L., Dahlberg J., Gazit A., Yaniv A., Tronick S.R., Aaronson S.A. Nucleotide sequence analysis of equine infectious anemia virus proviral DNA. Virology 1987, 158:300-312.
32. Kim D.Y., Kwon E., Hartley P.D., Crosby D.C., Mann S., Krogan N.J., Gross J.D. CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. Mol. Cell 2013, 49:632-644.
33. Klase Z., Yedavalli V.S.R.K., Houzet L., Perkins M., Maldarelli F., Brenchley J., Strebel K., Liu P., Jeang K.-T. Activation of HIV-1 from latent infection via synergy of RUNX1 inhibitor Ro5-3335 and SAHA. PLoS Pathog. 2014, 10:e1003997.
34. Lahaye X., Satoh T., Gentili M., Cerboni S., Conrad C., Hurbain I., El Marjou A., Lacabaratz C., Lelièvre J.D., Manel N. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 2013, 39:1132-1142.
35. LaRue R.S., Jónsson S.R., Silverstein K.A.T., Lajoie M., Bertrand D., El-Mabrouk N., Hötzel I., Andrésdóttir V., Smith T.P.L., Harris R.S. The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. BMC Mol. Biol. 2008, 9:104.
36. Larue R.S., Lengyel J., Jónsson S.R., Andrésdóttir V., Harris R.S. Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity. J.Virol. 2010, 84:8193-8201.
37. Lim E.S., Fregoso O.I., McCoy C.O., Matsen F.A., Malik H.S., Emerman M. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 2012, 11:194-204.
38. Löchelt M., Romen F., Bastone P., Muckenfuss H., Kirchner N., Kim Y.-B., Truyen U., Rösler U., Battenberg M., Saib A., et al. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. USA 2005, 102:7982-7987.
39. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 1993, 73:1067-1078.
40. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424:99-103.
41. Miyagi E., Kao S., Yedavalli V., Strebel K. CBFβ enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G. J.Virol. 2014, 88:4839-4852.
42. Münk C., Beck T., Zielonka J., Hotz-Wagenblatt A., Chareza S., Battenberg M., Thielebein J., Cichutek K., Bravo I.G., O'Brien S.J., et al. Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol. 2008, 9:R48.
43. Nisole S., Lynch C., Stoye J.P., Yap M.W. A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc. Natl. Acad. Sci. USA 2004, 101:13324-13328.
44. Ooms M., Brayton B., Letko M., Maio S.M., Pilcher C.D., Hecht F.M., Barbour J.D., Simon V. HIV-1 Vif adaptation to human APOBEC3H haplotypes. Cell Host Microbe 2013, 14:411-421.
45. Ramage H.R., Kumar G.R., Verschueren E., Johnson J.R., Von Dollen J., Johnson T., Newton B., Shah P., Horner J., Krogan N.J., Ott M. A combined proteomics/genomics approach links hepatitis Cvirus infection with nonsense-mediated mRNA decay. Mol. Cell 2015, 57:329-340.
46. Rasaiyaah J., Tan C.P., Fletcher A.J., Price A.J., Blondeau C., Hilditch L., Jacques D.A., Selwood D.L., James L.C., Noursadeghi M., Towers G.J. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 2013, 503:402-405.
47. Roguev A., Bandyopadhyay S., Zofall M., Zhang K., Fischer T., Collins S.R., Qu H., Shales M., Park H.O., Hayles J., et al. Conservation and rewiring of functional modules revealed by an epistasis map in fission yeast. Science 2008, 322:405-410.
48. Ryan C.J., Roguev A., Patrick K., Xu J., Jahari H., Tong Z., Beltrao P., Shales M., Qu H., Collins S.R., et al. Hierarchical modularity andthe evolution of genetic interactomes across species. Mol. Cell 2012, 46:691-704.
49. Sauter D., Schindler M., Specht A., Landford W.N., Münch J., Kim K.-A., Votteler J., Schubert U., Bibollet-Ruche F., Keele B.F., et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 2009, 6:409-421.
50. Sayah D.M., Sokolskaja E., Berthoux L., Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430:569-573.
51. Schwefel D., Groom H.C.T., Boucherit V.C., Christodoulou E., Walker P.A., Stoye J.P., Bishop K.N., Taylor I.A. Structural basis of lentiviral subversion of a cellular protein degradation pathway. Nature 2014, 505:234-238.
52. Sharp P.M., Hahn B.H. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med 2011, 1:a006841.
53. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646-650.
54. Sheehy A.M., Gaddis N.C., Malim M.H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 2003, 9:1404-1407.
55. Sokolskaja E., Luban J. Cyclophilin, TRIM5, and innate immunity to HIV-1. Curr. Opin. Microbiol. 2006, 9:404-408.
56. Spiess C., Miller E.J., McClellan A.J., Frydman J. Identification of the TRiC/CCT substrate binding sites uncovers the function of subunit diversity in eukaryotic chaperonins. Mol. Cell 2006, 24:25-37.
57. Stanley D.J., Bartholomeeusen K., Crosby D.C., Kim D.Y., Kwon E., Yen L., Cartozo N.C., Li M., Jäger S., Mason-Herr J., et al. Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G. PLoS Pathog. 2012, 8:e1003085.
58. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
59. Tahirov T.H., Inoue-Bungo T., Morii H., Fujikawa A., Sasaki M., Kimura K., Shiina M., Sato K., Kumasaka T., Yamamoto M., et al. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta. Cell 2001, 104:755-767.
60. Takahashi N., Hayano T., Suzuki M. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 1989, 337:473-475.
61. Tan M.J., White E.A., Sowa M.E., Harper J.W., Aster J.C., Howley P.M. Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. Proc. Natl. Acad. Sci. USA 2012, 109:E1473-E1480.
62. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C.T., Sodroski J., Göttlinger H.G. Functional association of cyclophilin A with HIV-1 virions. Nature 1994, 372:363-365.
63. Thériault Y., Logan T.M., Meadows R., Yu L., Olejniczak E.T., Holzman T.F., Simmer R.L., Fesik S.W. Solution structure of the cyclosporin A/cyclophilin complex by NMR. Nature 1993, 361:88-91.
64. White E.A., Kramer R.E., Tan M.J., Hayes S.D., Harper J.W., Howley P.M. Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity. J.Virol. 2012, 86:13174-13186.
65. White E.A., Sowa M.E., Tan M.J., Jeudy S., Hayes S.D., Santha S., Münger K., Harper J.W., Howley P.M. Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses. Proc. Natl. Acad. Sci. USA 2012, 109:E260-E267.
66. York A., Hutchinson E.C., Fodor E. Interactome analysis of the influenza A virus transcription/replication machinery identifies protein phosphatase 6 as a cellular factor required for efficient virus replication. J.Virol. 2014, 88:13284-13299.
67. Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., Yu X.F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003, 302:1056-1060.
68. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003, 424:94-98.
69. Zhang W., Du J., Evans S.L., Yu Y., Yu X.-F. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction. Nature 2012, 481:376-379.
70. Zhang J., Wu J., Wang W., Wu H., Yu B., Wang J., Lv M., Wang X., Zhang H., Kong W., Yu X. Role of cullin-elonginB-elonginC E3 complex in bovine immunodeficiency virus and maedi-visna virus Vif-mediated degradation of host A3Z2-Z3 proteins. Retrovirology 2014, 11:77.
71. Zhang W., Wang H., Li Z., Liu X., Liu G., Harris R.S., Yu X.-F. Cellular requirements for BIV Vif-mediated inactivation of bovine APOBEC3 proteins. J.Virol. 2014, Published online August 20, 2014. 10.1128/JVI.02072-14.